Literature DB >> 19494402

Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.

Nicolas W Shammas1, Gail Shammas, Darren Bryan, Jason Rauba, Eric Dippel, Michael Jerin.   

Abstract

BACKGROUND: Predictors of target lesion revascularization (TLR) have not been well defined in patients undergoing peripheral percutaneous interventions (PPI). In this study we analyze predictors of TLR in a consecutive cohort of patients from two medical centers.
METHODS: Data were extracted from a prospectively collected peripheral vascular registry. Of 105 consecutive patients (175 vessels) undergoing PPI, follow up was achieved in 104 patients (172 vessels) at 8.06 +/- 4.51 months. Univariate analysis was performed between the groups with (n = 19, vessels = 25) and without (n = 85, vessels = 147) TLR. Logistic regression analysis was utilized to model for the predictors of TLR.
RESULTS: TLR occurred in 14% of vessels treated at 8.06 +/- 4.51 months. By univariate analysis, vessels with TLR on follow up had longer treated segments (167.0 +/- 139.16 mm vs. 98.49 +/- 113.33 mm; p = 0.027), more severe lesions (91.96 +/- 12.56% vs. 85.51 +/- 14.43%; p = 0.037) and were younger (63.0 +/- 10.1 years vs. 69.1 +/- 11.1 years; p = 0.032). Also, there was a trend toward a higher hs-CRP (11.35 +/- 17.85 vs. 7.45 +/- 9.57 mg/L) and more total occlusions (44.0% vs. 22.6%) in the TLR group, but these did not reach statistical significance. Logistic regression analysis with backward elimination including all these variables showed that younger age (p = 0.007), female gender (p = 0.033) and treated vessel length (p = 0.028) were the only independent predictors of TLR.
CONCLUSIONS: Younger age, female gender and longer treated vessel length are independent predictors of TLR in patients undergoing PPI. The cost-effectiveness in treating these patients with PPI versus surgery needs to be defined in future studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494402

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.

Authors:  Alessandro Lupi; Gioel Gabrio Secco; Andrea Rognoni; Lidia Rossi; Maurizio Lazzero; Federico Nardi; Roberta Rolla; Giorgio Bellomo; Angelo Sante Bongo; Carlo Di Mario
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Usefulness of Platelet Distribution Width and Fibrinogen in Predicting In-stent Restenosis With Stable Angina and Type 2 Patients With Diabetes Mellitus.

Authors:  Dayang Chai; Xi Yang; Aichao Wang; Shu Lu; Yuxiang Dai; Jing Zhou
Journal:  Front Cardiovasc Med       Date:  2022-03-21

3.  Different doses of folic acid and vitamin B12 to treat rabbits with deep venous thrombosis and hyperhomocysteinemia.

Authors:  Xiao-Jun Shu; Zheng-Fei Li; Yao-Wen Chang; Sheng-Ye Liu; Wen-Hui Wang; Xiaoqiang Li
Journal:  Exp Ther Med       Date:  2018-01-15       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.